Our center is taking part in a phase 2/3, randomized, placebo controlled study of oral brepocitinib for adults with biopsy confirmed lichen planopilaris. The study is sponsored by Priovant Therapeutics (NCT07532603).
To ask whether the study may be right for you, call 781.744.8444. See all studies at our center.